VironervaPharmaceutical
About Vironerva

Leadership &
Regulatory Compliance

A team of world-class pharmaceutical scientists, regulatory experts, and operations leaders united by a singular mission: delivering life-altering neuro-therapeutics with uncompromising integrity.

Our Mission

Solving the Blood-Brain
Barrier Challenge

Vironerva is a specialized pharmaceutical architecture based in London, dedicated to the most consequential challenge in neuroscience: delivering therapeutic compounds across the blood-brain barrier with precision and molecular integrity.

Founded on breakthrough research in lipid-mediated transport, our proprietary VN-Platform™ technology has enabled a pipeline of neuro-therapeutic candidates addressing conditions from treatment-resistant depression to early-stage Alzheimer’s disease.

LondonHeadquartersUnited Kingdom
5Pipeline ProgramsActive Development
120+Team MembersAcross 8 Countries
12Patents FiledVN-Platform™ IP
Executive Team

Leadership Team

DH

Dr. Helena Whitford

Chief Executive Officer

Former VP of Neuroscience R&D at AstraZeneca. 20+ years in CNS drug development with 12 IND filings.

PhD Neuropharmacology, Cambridge
PK

Prof. Kenji Matsuda

Chief Scientific Officer

Pioneer in lipid nanoparticle delivery systems. Published 80+ peer-reviewed papers on BBB transport mechanisms.

MD/PhD, University of Tokyo
SC

Sarah Chen, MBA

Chief Operations Officer

Scaled HPAPI logistics for 3 Tier-1 pharma firms. Expert in cryogenic supply chain and GMP compliance.

MBA, London Business School
DM

Dr. Marcus Oyelaran

VP of Regulatory Affairs

Led 15+ successful NDA/BLA submissions. Deep expertise in MHRA, EMA, and FDA regulatory pathways.

PharmD, UCL School of Pharmacy
DI

Dr. Ingrid Svensson

Head of Quality Assurance

Architect of quality systems for 4 pharma startups. ICH Q7/Q10 specialist with 18 successful FDA inspections.

PhD Analytical Chemistry, KTH
JH

James Hargreaves, CFA

Chief Financial Officer

Previously CFO at two publicly traded biotech firms. Raised $800M+ in pharmaceutical capital markets.

CFA, MSc Finance, LSE
Compliance Framework

Regulatory Standards

MHRA

UK Medicines Act

Full compliance with the UK Medicines and Healthcare products Regulatory Agency (MHRA) framework.

ICH

ICH Q7 GMP

International Council for Harmonisation Good Manufacturing Practice for Active Pharmaceutical Ingredients.

ISO

ISO 9001:2015

Certified quality management system ensuring consistent product quality and regulatory adherence.

GDPR

GDPR Compliant

Full General Data Protection Regulation compliance for all partner data and corporate information.

Get in Touch

Contact &
Sample Request

To request a 2.0g Analytical Sample for verification purposes, or to discuss partnership opportunities, please complete the form. All inquiries are handled under strict NDA protocols.

Registered Office

Vironerva Ltd (UK)
Innovation Center, One Canada Square
Canary Wharf, London, E14 5AA
UK

General Enquiries

enquiries@vironerva.co.uk

Partner Relations

partnerships@vironerva.co.uk

All submissions are encrypted with TLS 1.3. Sample requests require institutional verification.